Literature DB >> 28947124

Epidemiology of Huntington disease.

Chris Kay1, Michael R Hayden1, Blair R Leavitt2.   

Abstract

Huntington disease (HD) is an autosomal-dominant neurologic disorder caused by an expanded CAG trinucleotide repeat mutation in patients with characteristic motor signs and specific brain pathology. A repeat of 36 CAG or more can lead to the disease, with increased penetrance and decreased age of onset at longer CAG repeats. The epidemiology of HD thus depends on ascertainment of individuals with the expanded CAG mutation, and on examination of clinical signs to accurately assess disease onset. A larger number of individuals have an expanded CAG repeat than actively manifest the disease due to adult onset in the majority of cases. Because of incomplete penetrance at the lower end of the pathogenic CAG repeat range, the frequency of the expanded CAG repeat in the general population may be higher than previously thought. Genetic differences and changing demographics may account for geographic and ethnic variation in the prevalence of HD between populations and over time. There are gross differences in the prevalence of HD by ancestry, with a much higher rate of the disease in populations of European descent. Molecular studies have elucidated genetic causes for these population-specific differences, possibly resulting from differences in the HD new mutation rate.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Huntington disease; de novo mutation; epidemiology; genetic testing; genetics; haplotypes; neurodegeneration; penetrance; prevalence; trinucleotide repeat

Mesh:

Year:  2017        PMID: 28947124     DOI: 10.1016/B978-0-12-801893-4.00003-1

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  14 in total

1.  Live births following preimplantation genetic testing for dynamic mutation diseases by karyomapping: a report of three cases.

Authors:  Dayuan Shi; Jiawei Xu; Wenbin Niu; Yidong Liu; Hao Shi; Guidong Yao; Senlin Shi; Gang Li; Wenyan Song; Haixia Jin; Yingpu Sun
Journal:  J Assist Reprod Genet       Date:  2020-03-02       Impact factor: 3.412

2.  Design and characterization of mutant and wildtype huntingtin proteins produced from a toolkit of scalable eukaryotic expression systems.

Authors:  Rachel J Harding; Peter Loppnau; Suzanne Ackloo; Alexander Lemak; Ashley Hutchinson; Brittany Hunt; Alex S Holehouse; Jolene C Ho; Lixin Fan; Leticia Toledo-Sherman; Alma Seitova; Cheryl H Arrowsmith
Journal:  J Biol Chem       Date:  2019-03-06       Impact factor: 5.157

Review 3.  Polyglutamine Repeats in Neurodegenerative Diseases.

Authors:  Andrew P Lieberman; Vikram G Shakkottai; Roger L Albin
Journal:  Annu Rev Pathol       Date:  2018-08-08       Impact factor: 23.472

4.  Structural neuroimaging differentiates vulnerability from disease manifestation in colombian families with Huntington's disease.

Authors:  Maria Del C Valdés Hernández; Janna Abu-Hussain; Xinyi Qiu; Josef Priller; Mario Parra Rodríguez; Mariana Pino; Sandra Báez; Agustín Ibáñez
Journal:  Brain Behav       Date:  2019-07-05       Impact factor: 2.708

Review 5.  Empathy In Neurodegenerative Diseases: A Systematic Review.

Authors:  Emanuele Pick; Johann R Kleinbub; Stefania Mannarini; Arianna Palmieri
Journal:  Neuropsychiatr Dis Treat       Date:  2019-11-22       Impact factor: 2.570

Review 6.  hiPSCs for predictive modelling of neurodegenerative diseases: dreaming the possible.

Authors:  Pia Rivetti di Val Cervo; Dario Besusso; Paola Conforti; Elena Cattaneo
Journal:  Nat Rev Neurol       Date:  2021-03-03       Impact factor: 42.937

7.  Inpatient gastrostomy in Huntington's disease: Nationwide analysis of utilization and outcomes compared to amyotrophic lateral sclerosis.

Authors:  Ali G Hamedani; Meredith Pauly; Dylan P Thibault; Pedro Gonzalez-Alegre; Allison W Willis
Journal:  Clin Park Relat Disord       Date:  2020-01-24

8.  High frequency of intermediary alleles in the HTT gene in Northern Sweden - The Swedish Huntingtin Alleles and Phenotype (SHAPE) study.

Authors:  Jimmy Sundblom; Valter Niemelä; Maria Ghazarian; Ann-Sofi Strand; Ingvar A Bergdahl; Jan-Håkan Jansson; Stefan Söderberg; Eva-Lena Stattin
Journal:  Sci Rep       Date:  2020-06-17       Impact factor: 4.996

9.  Economic burden of Huntington's disease in Peru.

Authors:  Gustavo Silva-Paredes; Rosa M Urbanos-Garrido; Miguel Inca-Martinez; Danielle Rabinowitz; Mario R Cornejo-Olivas
Journal:  BMC Health Serv Res       Date:  2019-12-30       Impact factor: 2.655

Review 10.  Juvenile Huntington's disease: two case reports and a review of the literature.

Authors:  Sigita Lesinskienė; Darja Rojaka; Rūta Praninskienė; Aušra Morkūnienė; Aušra Matulevičienė; Algirdas Utkus
Journal:  J Med Case Rep       Date:  2020-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.